about
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF ...
Read More
15.40
-0.18
(-1.16%)
2.7M
XNAS Volume
XNAS 11 Mar, 2026 3:20 PM (EDT)
Board Meeting
The next board meeting for Erasca Inc is on 20 Mar 2026 for the purpose of Erasca Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Erasca Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..